journal article·2019-05-14

Magnetic Photoluminescent Nanoplatform Built from Large-Pore Mesoporous Silica

Fan Yang, Artiom Skripka, Maryam Sadat Tabatabaei, Sung Hwa Hong, Fuqiang Ren, Yue Huang, Jung Kwon Oh, Sylvain Martel, Xinyu Liu, Fiorenzo Vetrone, Dongling Ma

Chemistry of Materials· Volume 31· Issue 9
Publisher page

Abstract

Integrating multiple components to realize cancer diagnosis and therapy in a single theranostic nanoplatform has drawn considerable attention. Herein, a multifunctional theranostic nanoplatform (mSiO2@PbS/CdS-Fe3O4) was successfully fabricated by carefully designing thiol-modified large-pore mesoporous silica nanospheres (mSiO2), followed by coordination-driven embedding of Fe3O4 nanoparticles (NPs) and PbS/CdS quantum dots (QDs) inside. The excellent feature of near-infrared (NIR) excitation and NIR emission of PbS/CdS QDs enables deep-tissue photoluminescence imaging, which was demonstrated ex vivo with tissue as thick as 14 mm. Meanwhile, owing to the presence of superparamagnetic Fe3O4 NPs, mSiO2@PbS/CdS-Fe3O4 can be rapidly confined under an external magnetic field (MF), and exhibit a significantly high T2 relaxivity in T2-weighted magnetic resonance (MR) images in vivo. When mSiO2@PbS/CdS-Fe3O4 was exposed to external physical stimuli of MF and/or NIR laser, they produced strong local heating through magnetothermal/photothermal effects. Owing to the unique mesoporous structure of mSiO2@PbS/CdS-Fe3O4, doxorubicin (DOX) was readily loaded into them and the drug-release profile was subsequently evaluated under multistimuli (pH/MF/NIR). The release of DOX was significantly enhanced at lower pH, and higher temperatures caused by magnetothermal/photothermal effects. Our results pave the road toward developing a highly powerful nanoplatform for bimodal imaging (NIR deep-tissue photoluminescence and MR imaging), and simultaneously for integrating synergistic treatment capabilities of hyperthermia and pH/MF/NIR-responsive drug release.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Advanced biosensing and bioanalysis techniques · Advanced Nanomaterials in Catalysis

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Institut National de la Recherche Scientifique, Centre Énergie, Matériaux et Télécommunications, Université du Québec, 1650 Boul. Lionel-Boulet, Varennes, Quebec J3X 1S2, Canada

NanoRobotics Laboratory, Department of Computer and Software Engineering, Institute of Biomedical Engineering, Polytechnique Montréal, Montreal, Quebec H3T 1J4, Canada

Department of Chemistry and Biochemistry, Concordia University, Montreal, Quebec H4B 1R6, Canada

Department of Mechanical and Industrial Engineering, University of Toronto, 5 King’s College Road, Toronto, Ontario M5S 3G8, Canada

Funding

Natural Sciences and Engineering Research Council of Canada · Minist?re de l??ducation, du Loisir et du Sport Qu?bec · Fonds de Recherche du Qu?bec - Nature et Technologies

References (53)

Show source-provided references
1. 10.1021/nn403089810.1021/nn4030898 ↗
2. 10.1002/anie.20060305210.1002/anie.200603052 ↗
3. 10.1038/ncomms609310.1038/ncomms6093 ↗
4. 10.1002/adfm.20120173310.1002/adfm.201201733 ↗
5. 10.1039/c2cc36059d10.1039/c2cc36059d ↗
6. 10.1016/j.biomaterials.2012.03.00710.1016/j.biomaterials.2012.03.007 ↗
7. 10.1002/adfm.20170623510.1002/adfm.201706235 ↗
8. 10.1021/acs.chemmater.8b0043110.1021/acs.chemmater.8b00431 ↗
9. 10.1021/acs.chemmater.7b0425310.1021/acs.chemmater.7b04253 ↗
10. 10.1021/cm052067x10.1021/cm052067x ↗
11. 10.1021/nl202949y10.1021/nl202949y ↗
12. 10.1002/adma.20080315910.1002/adma.200803159 ↗
13. 10.1039/C5NH00073D10.1039/C5NH00073D ↗
14. 10.1002/adfm.20180710510.1002/adfm.201807105 ↗
15. 10.1021/acs.chemrev.5b0032110.1021/acs.chemrev.5b00321 ↗
16. 10.1039/C4NR05342G10.1039/C4NR05342G ↗
17. 10.1016/j.biomaterials.2013.01.08410.1016/j.biomaterials.2013.01.084 ↗
18. 10.1021/nn401717910.1021/nn4017179 ↗
19. 10.7150/thno.881810.7150/thno.8818 ↗
20. 10.1002/adfm.20110274610.1002/adfm.201102746 ↗
21. 10.1002/smll.20120174310.1002/smll.201201743 ↗
22. 10.1002/adfm.20140307910.1002/adfm.201403079 ↗
23. 10.1039/C4NR07335E10.1039/C4NR07335E ↗
24. 10.1039/C2CC38417E10.1039/C2CC38417E ↗
25. 10.2217/17435889.3.2.13710.2217/17435889.3.2.137 ↗
26. 10.1002/adfm.20110205210.1002/adfm.201102052 ↗
27. 10.1021/nl404316v10.1021/nl404316v ↗
28. 10.1002/adma.20140081510.1002/adma.201400815 ↗
29. 10.1039/C1DT11399B10.1039/C1DT11399B ↗
30. 10.1016/S0927-7757(02)00048-110.1016/S0927-7757(02)00048-1 ↗
31. 10.1021/nl201820r10.1021/nl201820r ↗
32. 10.1002/adfm.20150263210.1002/adfm.201502632 ↗
33. 10.1039/C7TA01372H10.1039/C7TA01372H ↗
34. 10.1002/ppsc.20160024210.1002/ppsc.201600242 ↗
35. 10.1016/j.ccr.2016.03.00210.1016/j.ccr.2016.03.002 ↗
36. 10.1039/C6CP05786A10.1039/C6CP05786A ↗
37. 10.1021/acsami.7b0614510.1021/acsami.7b06145 ↗
38. 10.1021/ja203259710.1021/ja2032597 ↗
39. 10.1002/adfm.20170538010.1002/adfm.201705380 ↗
40. 10.1021/nn101016f10.1021/nn101016f ↗
41. 10.1021/ac061030910.1021/ac0610309 ↗
42. 10.1016/S0304-8853(99)00238-310.1016/S0304-8853(99)00238-3 ↗
43. 10.1039/b104562h10.1039/b104562h ↗
44. 10.1038/srep1213510.1038/srep12135 ↗
45. 10.1021/acsnano.8b0656310.1021/acsnano.8b06563 ↗
46. 10.1039/C6SC01359G10.1039/C6SC01359G ↗
47. 10.1021/nn101670k10.1021/nn101670k ↗
48. 10.1021/nn400824b10.1021/nn400824b ↗
49. 10.1021/nn204591r10.1021/nn204591r ↗
50. 10.1038/ncomms1546810.1038/ncomms15468 ↗
51. 10.1186/1475-2867-13-8910.1186/1475-2867-13-89 ↗
52. 10.1038/s41467-018-04910-510.1038/s41467-018-04910-5 ↗
53. 10.1021/am404165210.1021/am4041652 ↗